Hexamer Therapeutics
Pullman, US · Founded 2019
Biotech
Founders & leadership
KD
Keith David MillerExecutive Officer, Director, Promoter
RH
Robert Hale BogdenExecutive Officer, Director, Promoter
CC
Colin Conrad CollinsExecutive Officer, Director, Promoter
Reported raises · per SEC filings
Form D private placements$651.3KraisedJun 2024 · 9 investors · Biotechnology
Rule 506(b)$469.7KraisedDec 2019 · 3 investors · Biotechnology
Rule 506(b)Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.